Walgreens Boots Alliance, Inc. (NASDAQ:WBA)‘s stock had its “buy” rating restated by analysts at Jefferies Group LLC in a research note issued on Thursday. They presently have a $95.00 target price on the pharmacy operator’s stock. Jefferies Group LLC’s price target points to a potential upside of 16.48% from the company’s previous close.

Several other brokerages have also commented on WBA. Morgan Stanley restated an “overweight” rating and set a $95.00 price target on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. BidaskClub upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday, August 30th. Citigroup Inc. reiterated a “buy” rating on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Loop Capital initiated coverage on Walgreens Boots Alliance in a research note on Thursday, August 24th. They issued a “buy” rating and a $95.00 target price on the stock. Finally, Guggenheim reiterated a “buy” rating on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fourteen have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $91.81.

Walgreens Boots Alliance (NASDAQ:WBA) traded down 0.24% during mid-day trading on Thursday, hitting $81.56. 5,467,380 shares of the stock were exchanged. The stock has a market cap of $87.28 billion, a price-to-earnings ratio of 20.60 and a beta of 1.26. Walgreens Boots Alliance has a 52-week low of $75.18 and a 52-week high of $88.00. The stock has a 50 day moving average of $80.69 and a 200-day moving average of $82.16.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, beating the consensus estimate of $1.30 by $0.03. The firm had revenue of $30.12 billion for the quarter, compared to analyst estimates of $29.72 billion. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The business’s revenue for the quarter was up 2.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.18 earnings per share. Equities analysts predict that Walgreens Boots Alliance will post $5.00 EPS for the current fiscal year.

Walgreens Boots Alliance announced that its board has approved a share buyback program on Thursday, June 29th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the pharmacy operator to buy up to 5.9% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s leadership believes its stock is undervalued.

WARNING: “Walgreens Boots Alliance’s (WBA) Buy Rating Reaffirmed at Jefferies Group LLC” was first posted by American Banking News and is the property of of American Banking News. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/09/07/walgreens-boots-alliances-wba-buy-rating-reaffirmed-at-jefferies-group-llc.html.

In related news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction dated Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total transaction of $218,305.44. Following the completion of the sale, the director now owns 19,151 shares of the company’s stock, valued at $1,528,058.29. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 13.50% of the company’s stock.

Institutional investors have recently added to or reduced their stakes in the stock. Hudock Capital Group LLC lifted its holdings in shares of Walgreens Boots Alliance by 0.5% during the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after purchasing an additional 6 shares during the period. Westside Investment Management Inc. lifted its holdings in shares of Walgreens Boots Alliance by 10.4% during the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock worth $102,000 after purchasing an additional 125 shares during the period. Reilly Financial Advisors LLC lifted its holdings in shares of Walgreens Boots Alliance by 7.9% during the second quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock worth $107,000 after purchasing an additional 100 shares during the period. Tarbox Group Inc. lifted its holdings in shares of Walgreens Boots Alliance by 288.3% during the first quarter. Tarbox Group Inc. now owns 1,355 shares of the pharmacy operator’s stock worth $113,000 after purchasing an additional 1,006 shares during the period. Finally, Webster Bank N. A. lifted its holdings in shares of Walgreens Boots Alliance by 18.4% during the first quarter. Webster Bank N. A. now owns 1,509 shares of the pharmacy operator’s stock worth $125,000 after purchasing an additional 235 shares during the period. 60.18% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.